Evidence map›Paper›PMID 41053828›Full record

ArticleRespiratory research2025

Pseudomonas aeruginosa infection exacerbates elastase induced lung damage: characterisation of a novel murine two-hit model of pulmonary infection.

Carla A Gustafsson, Sathayanarayani Srishanmuganathan, Anna V Kelis, Mohamed-Amiin Muhidiin, Yanira Riffo-Vasquez, Carolyn Lam, Clive P Page, Simon C Pitchford, Richard T Amison

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carla A GustafssonUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Sathayanarayani SrishanmuganathanUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Anna V KelisUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Mohamed-Amiin MuhidiinUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Yanira Riffo-VasquezUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Carolyn LamUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Clive P PageUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Simon C PitchfordUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Richard T AmisonUnit of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Science, King's College London, London, SE1 9NH, UK. richard.amison@kcl.ac.uk.

Funding

LIDo Doctoral Training Grant BB/M009513/1LIDo Doctoral Training Grant BB/T008709/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/T001240/1Royal Society RGS\R2\202195
6 · The paper itself

Abstract

backgroundPulmonary bacterial infections remain a hallmark of a range of respiratory diseases including Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Disease (COPD) and non-CF bronchiectasis (NCFBE). Chronic persistent infections in the lung including P. aeruginosa are characterised by periods of stability punctuated by acute pulmonary exacerbations (PExs). Whilst animal infection models can reliably replicate acute and stable chronic infections, none currently replicate appropriate 'acute-on-chronic' pathophysiological backgrounds required to model PExs. Here, we aimed to establish a novel two-hit model of chronic P. aeruginosa infection where animals were first subjected to elastase challenge inducing pulmonary inflammation and injury reflective of the CF/COPD lung and subsequently infected with P. aeruginosa, utilised for its commonality across PExs in CF, COPD and NCFBE patients.

methodsMice were challenged with 2 mg/kg Porcine Pancreatic Elastase (PPE) on days 1, 4 and 7 before infection with 1 × 10

resultsPPE induced significant pulmonary neutrophil recruitment alongside structural markers of lung injury characteristic of CF, COPD and NCFBE. In the two-hit cohort, bacterial clearance following P. aeruginosa infection was significantly impaired in animals first subjected to repeated elastase challenge. This was accompanied by exacerbated neutrophilic recruitment and activation, accelerating PPE induced lung damage characteristic of PExs.

conclusionsTaken together, this two-hit model of pulmonary infection with P. aeruginosa following PPE induced lung injury replicates key pathophysiological changes consistent with PExs relevant to CF, COPD and NCFBE patients.

Indexed as

Disease Models, AnimalLungLung InjuryPancreatic ElastasePneumonia, BacterialPseudomonas aeruginosaPseudomonas InfectionsAnimalsFemaleMaleMiceMice, Inbred C57BLPancreatic ElastaseChronic Obstructive Pulmonary DiseaseCystic FibrosisInfectionsPseudomonas aeruginosaPulmonary exacerbations

Identifiers

PMID41053828
PMCPMC12502232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.